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Telomere length is important in tumorigenesis. Using quantitative real-time PCR, we prospectively measured
relative telomere length in a nested case–control study within the Nurses’ Health Study: 218 melanoma cases,
285 squamous-cell carcinoma (SCC) cases, 300 basal-cell carcinoma (BCC) cases, and 870 controls. We observed
that shorter telomeres were associated with a decreased number of moles (P¼ 0.002) and a decreased risk of
melanoma. Women in the second and first quartiles, those with the shortest telomere length, had an odds ratio
(OR) for melanoma of 0.54 (95% confidence interval (CI), 0.29–1.01) and 0.59 (95% CI, 0.31–1.13), respectively,
compared with those in the fourth quartile (P, trend¼ 0.09). There was no clear trend between telomere length
and SCC risk. In contrast, we found that shorter telomere length was associated with an increased risk of BCC.
Compared with those in the fourth quartile, women in the first quartile had an OR of 1.85 (95% CI, 0.94–3.62)
(P, trend¼ 0.09). The opposing associations observed should be interpreted with caution, and further research is
needed to confirm these possible associations.
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INTRODUCTION
Telomeres are long hexameric (TTAGGG) n repeats at the ends
of the p and q arms of linear eukaryotic chromosomes. Studies
in mice and yeast have demonstrated the critical role of
telomeres in maintaining the structural integrity of chromo-
somes by preventing fusion of chromosomal ends, nucleolytic
decay, end-to-end fusion, and atypical recombination
(Lundblad and Szostak, 1989). However, at each cell division,
DNA polymerases fail to completely replicate telomeres,
resulting in cumulative erosion of the telomeres (Chang and
Harley, 1995; Chan and Blackburn, 2004). Telomeric repeats
shorten by 30–200bp after each cycle of mitotic division and
have been likened to a ‘‘molecular clock’’ reflecting the
number of divisions a cell has undergone (Harley, 1997) and
ultimately determines the replication potential of a cell. When
telomeres shorten to a critical length, the cells undergo
senescence, apoptosis, or become genomically unstable.
Shorter telomere length has been previously reported to be
associated with an increased risk of various cancers (Wu et al.,
2003; Broberg et al., 2005; Avigad et al., 2007; McGrath et al.,
2007; Risques et al., 2007; Shao et al., 2007; Shen et al., 2007;
Widmann et al., 2007).
Ultraviolet light B-induced pyrimidine dimers occur at
high frequency in telomere regions, indicating that long
repeats of telomere sequences are targets for ultraviolet light
B (Jin and Ikushima, 2004). Although the precise mechanism
is not known, it has been reported that UV-damaged
telomeric DNA is less well repaired than the transcriptionally
active region (Kruk et al., 1995). Unrepaired ultraviolet light
B lesions cause daughter-strand gaps during DNA replication
(Wang and Smith, 1986), resulting in substantial loss of
terminal telomere repeats or telomere shortening. In addition,
UVA can indirectly cause oxidative stress via reactive oxygen
species generated after the absorption of light energy by
cellular chromophores (Hall and Johnson, 1996; Brash, 1997;
Kielbassa et al., 1997). Oxidative stress may lead to telomere
shortening (Houben et al., 2008). Truncated telomeres lead to
genomic instability and are one of the defining characteristics
of most carcinomas (Maser and DePinho, 2002).
The three major types of cells in the epidermis, melano-
cytes, basal keratinocytes, and squamous keratinocytes, give
rise to melanoma, basal-cell carcinoma (BCC), and squa-
mous-cell carcinoma (SCC), respectively. Melanocytes reside
on the basal layer of the epidermis exhibiting less apoptotic
activity and less differentiation than keratinocytes (Gilchrest
et al., 1999). A brief spurt of melanocyte proliferation gives
rise to melanocytic nevi, benign tumors commonly referred
to as moles, which are strongly associated with an increased
risk of melanoma. Shorter telomere length may limit
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melanocytic nevus proliferation before entry into senescence
and has been shown to be associated with decreased mole
counts and size (Bataille et al., 2007). On the other hand,
squamous keratinocytes on the surface of the epidermis
undergo continual cycles of proliferation and apoptosis
throughout a lifetime. Basal cells, which give rise to BCC,
are less susceptible to apoptosis than squamous keratinocytes
(Gilchrest et al., 1999) and have a lower tendency to senesce
than melanocytes. Because of the distinct proliferative
features of these skin cells, telomere length may play a
different role in the etiology of these three types of skin
cancers.
To this end, we prospectively evaluated the association
between prediagnostically measured telomere length and risk
of three types of skin cancers (melanoma, BCC, and SCC)
simultaneously in a nested case–control study within the
Nurses’ Health Study.
RESULTS
Descriptive characteristics of cases and controls
The characteristics of cases and controls in the skin cancer
nested case–control study are presented in Table 1. Detailed
description was published previously (Han et al., 2006). In
brief, at the beginning of the follow-up (at blood collection),
the age of the women was between 43 and 68 years (mean
age 58.7). The mean age at diagnosis of incident melanoma
cases was 63.3 years, and that of SCC cases and BCC cases
was 64.7 and 64.0 years, respectively. Risk factors for skin
cancer included family history of skin cancer, sun exposure
with a bathing suit, sunlamp use or tanning salon attendance,
and lifetime sunburns. Melanoma cases were more likely to
have a higher number of moles on the arms. Across all three
types of skin cancers, cases were more likely to have light
pigmentary phenotypes, including lighter skin and hair color,
less tendency to tan, and increased tendency to burn. For
mole counts among controls, the mean was 5.1; the median
was 1.0; and the 90 and 10% of the distribution were 15 and
0, respectively.
Risk factors and telomere length
We observed that age at blood draw and pack-years of
smoking were weakly inversely associated with telomere
length among overall controls (Table 2). This is consistent
with previous findings that telomeres shorten with age
(Frenck et al., 1998) and cigarette smoking because of
oxidative stress (Valdes et al., 2005). We also observed that
there was a positive association between the number of
moles on arms and telomere length (r¼0.17, P¼0.002). The
Table 1. Characteristics of skin cancer cases and controls in the nested case–control study
Characteristic
Controls
(n=870)
Melanoma cases
(n=218)
SCC cases
(n=285)
BCC cases
(n=300)
Age at diagnosis, mean (SD) 64.5 (7.0) 63.3 (7.3) 64.7 (7.0) 64.0 (7.1)
Age at blood draw, mean (SD) 58.8 (6.8) 57.4 (7.0) 59.3 (6.7) 58.3 (6.6)
Family history of skin cancer (%) 25.1 36.5 35.7 42.7
Highest quartile of sun exposure with a bathing suit (%) 33.4 53.3 46.1 42.6
Sunlamp use or tanning salon attendance (%) 10.0 19.2 14.3 14.7
Number of lifetime severe sunburns (mean) 5.4 9.6 7.8 8.2
Number of moles on arms, mean (SD) 5.1 (10.3) 11.3 (21.9) 4.8 (12.0) 7.7 (17.3)
Childhood tendency to tan (%) 48.0 38.8 42.7 45.0
Childhood tendency to burn (%) 33.0 49.8 51.0 52.0
Natural red or blonde hair color (%) 12.5 23.3 20.3 20.7
Natural fair skin color (%) 39.9 57.1 54.6 53.0
Pack-year of smoking1, mean (SD) 22.5 (19.0) 20.9 (18.7) 22.7 (18.0) 22.9 (18.9)
BCC, basal-cell carcinoma; SCC, squamous-cell carcinoma; SD, standard deviation.
1Only among smokers.
Table 2. Spearman’s correlation between telomere
length and risk factors among controls
Coefficient (P-value)
Age at blood draw 0.09 (0.01)
Age at blood draw1 0.09 (0.007)
Pack-years of smoking2 0.05 (0.15)
Moles on arms 0.17 (0.002)
Moles on arms2 0.16 (0.003)
Natural hair color (black to red) 0.02 (0.49)
Natural skin color (fair to black) 0.02 (0.54)
Childhood tendency to tan 0.02 (0.58)
Childhood tendency to burn 0.03 (0.44)
Sun exposure while wearing a bathing suit2 0.02 (0.62)
1Controlling for pack-years of smoking.
2Controlling for age at blood draw.
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result was essentially the same after adjusting for age. In each
quartile group of telomere length among overall controls, the
mean age-adjusted number of moles was 4.4, 5.0, 5.3, and
5.8, respectively (P, trend¼0.09). In contrast, there was no
association between telomere length and other inherited risk
factors and sun exposure.
Telomere length and skin cancer risk
We examined the association between relative telomere
length and each type of skin cancer separately (Table 3). We
categorized the participants into quartiles based on the
relative telomere length distribution of the controls; the fourth
quartile, the longest telomere length, served as the reference.
We observed that shorter telomere length was associated
with a decreased risk of melanoma. Women in the second
and first quartiles, those with the shortest telomere length,
had an odds ratios (OR) for melanoma of 0.54 (95%
confidence interval (CI), 0.29–1.01) and 0.59 (95% CI,
0.31–1.13) compared with those in the fourth quartile
(P, trend¼0.09). In contrast, we observed that shorter
telomere length was associated with an increased risk of
BCC. Compared with women in the fourth quartile, those in
the first quartile had an OR of 1.85 (95% CI, 0.94–3.62)
(P, trend¼ 0.09). No association was observed between
telomere length and SCC risk. The results across the three
types of skin cancers were essentially the same after
controlling for the number of moles on the arms.
We did not observe a significant interaction between
telomere length and the number of moles on skin cancer risk.
DISCUSSION
To our knowledge, this is the first prospective study
addressing the potential contributions of relative telomere
length to skin cancer risk. Relative telomere length measured
prediagnostically in peripheral blood leukocytes (PBLs) was
differentially associated with risk of three types of skin cancer
(melanoma, BCC, and SCC) in women. These results were not
statistically significant and should be interpreted with
caution. Further studies are needed to confirm these possible
findings.
Telomere shortening plays conflicting roles in cancer
development. On one hand, the progressive loss of telomeric
repeats with each cell division limits the total number of
times a cell can divide. A DNA damage response is triggered
once telomeres reach a critical length causing the cell to
undergo senescence or apoptosis. Senescent cells express
b-galactosidase, develop a characteristic flat and vacuole-
rich cytoplasmic morphology, and undergo a permanent and
irreversible cell-cycle arrest in G1 phase, but remain
metabolically active (Mooi and Peeper, 2006). This constraint
on proliferation prevents the accumulation of oncogenic
mutations and subsequent malignant transformation. How-
ever, if this checkpoint is bypassed, the cell continues to
proliferate resulting in additional telomere erosion (Hackett
Table 3. Association between relative telomere length and skin cancer risk
Relative telomere length (T/S ratio)1 Case, n (%) Control, n (%) OR (95% CI)2 OR (95% CI)3
Melanoma
Fourth quartile (41.40) 63 (30.9) 55 (24.8) 1.00 1.00
Third quartile (1.15–1.40) 49 (24.0) 54 (24.3) 0.76 (0.43–1.34) 0.79 (0.44–1.41)
Second quartile (0.97–1.15) 44 (21.6) 58 (26.1) 0.54 (0.29–1.01) 0.57 (0.30–1.00)
First quartile (o0.97) 48 (23.5) 55 (24.8) 0.59 (0.31–1.13) 0.62 (0.31–1.23)
P, trend 0.09 0.15
SCC
Fourth quartile (41.44) 61 (24.0) 67 (24.5) 1.00 1.00
Third quartile (1.08–1.44) 78 (30.7) 70 (25.6) 1.24 (0.71–2.15) 1.19 (0.67–2.12)
Second quartile (0.85–1.08) 59 (23.2) 67 (24.5) 0.90 (0.48–1.71) 0.89 (0.46–1.72)
First quartile (o0.85) 56 (22.0) 69 (25.3) 0.73 (0.34–1.55) 0.72 (0.33–1.55)
P, trend 0.30 0.29
BCC
Fourth quartile (41.52) 57 (20.2) 75 (24.5) 1.00 1.00
Third quartile (1.17–1.52) 76 (27.0) 79 (25.8) 1.46 (0.85–2.52) 1.49 (0.86–2.59)
Second quartile (0.90–1.17) 74 (26.2) 76 (24.8) 1.57 (0.86–2.87) 1.61 (0.88–2.96)
First quartile (o0.90) 75 (26.6) 76 (24.8) 1.85 (0.94–3.62) 1.87 (0.95–3.68)
P, trend 0.09 0.09
BCC, basal-cell carcinoma; CI, confidence interval; SCC, squamous-cell carcinoma; OR, odds ratio.
1Relative T/S ratio has been described in detail in the text.
2Conditional logistic regression.
3Conditional logistic regression adjusted for the number of moles on arms.
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and Greider, 2002; Wong and Collins, 2003). Once a
threshold length of 12.8 repeats (77 bp) is reached, chromo-
some ends become fusogenic resulting in chromosome
instability (Capper et al., 2007), which may also potentially
lead to malignant transformation.
The opposing associations observed between relative
telomere length and the various skin cancers may stem from
the proliferative characteristics of the corresponding cell
types from which the cancers arise and how they deal with
telomere shortening. Presumably cutaneous melanocytes are
evolutionarily preserved because they produce melanin,
which is responsible for constitutional skin pigmentation
and protective tanning response to UV. They are characte-
rized by low levels of proliferation and a limited capacity to
undergo apoptosis, perhaps because of a high content of
antiapoptotic proteins, such as BCL2 and Slug (Mooi and
Peeper, 2006). Frequently, activating mutations of the BRAF
oncogene occur in melanoctyes, resulting in a transient
increase in proliferation and the formation of melanocytic nevi
(Gray-Schopfer et al., 2006). Rather than undergo apoptosis,
these melanocytes are more likely to senesce in response to
oncogenic stress, which allows them to remain functional
while preventing the propagation of the oncogenic mutation
(Mooi and Peeper, 2006). It has been hypothesized that
mutated cells with longer telomere lengths experience a delay
in senescence as a result of the greater replication potential.
Prolonged nevus development leads to the increased formation
of nevi, which are strongly associated with an increased risk of
melanoma (Bastian, 2003). Consistent with this hypothesis, we
observed a positive association between relative telomere
length and risk of melanoma.
In contrast to melanocytes, squamous keratinocytes are
well-differentiated cells that form the uppermost layer of skin.
These cells have a lower apoptotic threshold making the
apoptotic pathway the predominant protective mechanism,
especially when cells are challenged by genotoxic stress such
as UV-induced DNA damage. Sunburn cells are squamous
keratinocytes undergoing apoptosis. Programmed cell death
is also part of the normal terminal differentiation process that
squamous keratinocytes undergo to form the water-resistant,
outermost protective layer of the epidermis (Nemes and
Steinert, 1999). This process is presumably independent of
telomere length. As a result, it is not surprising that we did not
observe an association between relative telomere length and
SCC risk.
Basal cells, which give rise to BCC, are less susceptible to
apoptosis than squamous keratinocytes (Gilchrest et al.,
1999) and have a lower tendency to senescence than
melanocytes. The proliferative demand of basal cells coupled
with UV-induced damage of telomeric DNA may increase
the likelihood of unstable telomeres and trigger chromosomal
rearrangements. Under these circumstances, cells with
comparatively shorter telomere lengths may potentially reach
genomic instability within a smaller number of cell divisions
and therefore be at greater risk for malignant transformation.
Such a mechanism may explain the association we observed
between shorter relative telomere lengths and an increased
risk of BCC in our study population.
Although replicative senescence has been hypothesized to
halt the initial growth of melanocytic nevi (Bastian, 2003),
experimental evidence suggests otherwise. It is believed that
activating mutations in BRAF, which are found in 82% of nevi
(Pollock et al., 2003), initiate the development of nevi with
the onset of rapid proliferation. The proliferation is transient
as it is generally followed by an increase in expression of p16,
resulting in growth arrest and a senescent phenotype in a
process known as oncogene-induced senescence. Telomere
attrition does not appear to be the main contributor to the
initial growth arrest as telomere length in nevi did not differ
significantly from surrounding tissue and nevi generally lack
expression of p53 and p21, markers of telomere-induced
senescence. These cells can remain arrested for decades
(Michaloglou et al., 2005; Gray-Schopfer et al., 2006; Mooi
and Peeper, 2006).
It has also been noted that atypical nevi and early
melanomas express p53 and p21, and that p16 is deleted or
silenced in a majority of primary melanomas (Gray-Schopfer
et al., 2006). Although telomere attrition may not be involved
in the initial formation of melanocytic nevi, these observa-
tions suggest replicative senescence may act as a second line
of defense in melanocytes. If melanocytes eventually escape
oncogene-induced senescence and reenter the cell cycle,
cells with short telomeres will reach the critical length earlier
causing cells to undergo replicative senescence or apoptosis,
which may explain the inverse correlation between number
of nevi and age in individuals over 30 years of age (Bataille
et al., 2007). Longer telomeres in melanocytes, which already
have two oncogenic mutations (activating BRAF and
silenced/deleted p16), may result in delayed senescence or
apoptosis providing these cells with a greater opportunity to
acquire additional mutations, increasing the probability of
malignant transformation. The positive association we
observed between relative telomere length and melanoma
risk would be consistent with such a mechanism.
In this study, we used self-reported information on nevus
counts. The validity of self-reported nevus counts was
evaluated in previous studies. For example, the majority of
studies on nevus counts have shown substantial agreement
between nevus self-counts and dermatologist counts (Little
et al., 1995; Buettner and Garbe, 2000; Melia et al., 2000).
The Spearman’s correlation coefficient was 0.91 between
nevus counts by patients and physicians, suggesting quite a
good correlation between the two measurements (Mikkilineni
and Weinstock, 2000). Some case–control studies involving
self-counts of nevi have demonstrated a substantial correla-
tion of those counts with melanoma risk (Weinstock et al.,
1989; Lawson et al., 1994). We did not have information on
the total number of body moles and used the number of
moles on the arms as a proxy for the total body mole counts.
We previously examined moles on all four limbs versus one
limb in relation to melanoma risk and found that the risks
calculated from both calculations were comparable (Bain
et al., 1988).
We used real-time PCR and DNA derived from PBLs to
determine relative telomere length. The observed correlation
with age and cigarette smoking confirms that real-time PCR
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provides a biologically meaningful measure of telomere
length. Measuring telomeres by real-time PCR is currently the
most economical and versatile high-throughput method. It
generates a T/S ratio that is proportional to a cell’s average
telomere length. Although the values are not an actual
kilobase pair length of telomeres as do Southern blots, the
relative T/S ratio has been confirmed to be highly consistent
with the Southern blot assay, which measures telomere
length as terminal restriction fragments (Cawthon, 2002). In
fact, the coefficients of variation between replicates are often
below 5% whereas densitometry readings from Southern
blots range between 10 and 15%. In addition, the real-time
PCR method does not pick up subtelomeric DNA like
Southern blots.
Even though relative telomere lengths were not directly
measured in melanocytes and keratinocytes, PBLs represent a
good proxy for telomere length in other tissues of the same
individual, including skin (Friedrich et al., 2000). The
correlation between the PBL telomere length and mole
counts observed in our study and the previous study (Bataille
et al., 2007) further suggests the biological relevance of the
relative telomere length measure in the PBL.
In summary, our findings suggest the involvement of
telomere length in the development of skin cancer. Distinct
genetic constitutions across different types of cells and tissues
evoke different DNA damage responses against telomere
shortening and malignant transformation. Nevertheless, we
cannot exclude the possibility that these findings may be
because of chance. Further research is needed to confirm
these possible associations.
MATERIALS AND METHODS
Study population
The Nurses’ Health Study was established in 1976, when 121,700
female registered nurses between the ages of 30 and 55, residing in
11 larger US states, completed a self-administered questionnaire on
their medical histories and baseline health-related exposures.
Updated information has been obtained by questionnaires every
2 years. Between 1989 and 1990, blood samples were collected
from 32,826 of the cohort members. The distribution of risk factors
for skin cancer in the subcohort of those who donated blood samples
was very similar to that in the overall cohort (Han et al., 2006).
Eligible cases in this study were women with incident skin cancer
from the subcohort who had given a blood specimen, including SCC
and BCC cases with a diagnosis any time after blood collection up to
1 June 1998 and melanoma cases up to 1 June 2000 who had no
previously diagnosed skin cancer. A common control series was
randomly selected from participants who gave a blood sample and
were free of diagnosed skin cancer up to and including the
questionnaire cycle in which the case was diagnosed. One or two
controls were matched to each case by year of birth (±1 year). All
cases and controls were self-described as being of European
ancestry. The nested case–control study consisted of 218 melanoma
cases, 285 SCC cases, 300 BCC cases, and 870 matched controls.
The study protocol was approved by the Committee on Use of
Human Subjects of the Brigham and Women’s Hospital, Boston,
MA. The clinical investigation was conducted according to the
Declaration of Helsinki principles, and written informed consent
was obtained from all the patients.
Exposure data
Information regarding skin cancer risk factors was obtained from the
prospective biennial questionnaires and the retrospective supple-
mentary questionnaire. Questions on natural hair color, childhood
and adolescent tanning tendency, and childhood sunburn reaction
were asked in the 1982 prospective questionnaire; the number of
moles on arms (larger than 3mm diameter) in the 1986 prospective
questionnaire. In the skin cancer nested case–control study, natural
skin color and other sun exposure-related information was collected
by the retrospective supplementary questionnaire in 2002. Estima-
tion of past sunlight exposure for each subject was described
previously (Han et al., 2006).
Laboratory assays
Genomic DNA was extracted from buffy coat fractions using the
QIAmp (Qiagen, Chatsworth, CA) 96-spin blood protocol. We
conducted a pico-green quantitation using a Molecular Devices
96-well spectrophotometer and confirmed results using a Nanodrop
SD-1000 spectrophotometer. Subsequent standardization by drying
down the genomic DNA and resuspending ensured accurate and
uniform DNA concentrations.
We employed a modified version of the real-time PCR telomere
assay for use in a high-throughput 384-well format with an Applied
Biosystems’ 7900HT PCR System to determine the relative average
telomere length. Briefly, 5 ng of buffy-coat-derived genomic DNA
was dried down in a 384-well plate and resuspended in 10 ml of
either the telomere or 36B4 PCR reaction mixture for 2 hours at 4 1C.
The telomere reaction mixture consisted of 1 Qiagen Quantitect
Sybr Green Master Mix, 2.5mM of DTT, 270 nM of Tel-1b primer
(GGTTTTTGAGGGTGAGGGTGAGGGTGAGGGTGAGGGT), and
900nM of Tel-2b primer (TCCCGACTATCCCTATCCCTATCCCTATC
CCTATCCCTA). The reaction proceeded for 1 cycle at 95 1C for 5
hours, followed by 40 cycles at 95 1C for 15 minutes, and 54 1C for 2
hours. The 36B4 reaction consisted of 1 Qiagen Quantitect Sybr
Green Master Mix, 300 nM of 36B4U primer (CAGCAAGTGGGAAG
GTGTAATCC), and 500nM of 36B4D primer (CCCATTCTATCATCA
ACGGGTACAA). The 36B4 reaction proceeded for 1 cycle at 95 1C
for 5 hours, followed by 40 cycles at 95 1C for 15 minutes, and 58 1C
for 1 hour 10 minutes. All samples for both the telomere and single-
copy gene (36B4) reactions were performed in triplicate on different
plates, and the threshold value for both reactions was set to 0.5. In
addition to the samples, each 384-well plate contained a six-point
standard curve from 1.25 to 30 ng using pooled buffy-coat-derived
genomic DNA. The purpose of the standard curve was to assess and
compensate for interplate variations in PCR efficiency. The slope of
the standard curve for both the telomere and 36B4 reactions were
3.55±0.15, and acceptable linear correlation coefficient (R2)
value for both reactions were 0.98 and 0.99, respectively. The T/S
ratio (DCt) for each sample was calculated by subtracting the
average 36B4 threshold cycle (Ct) value from the average telomere
Ct value. The relative T/S ratio (DDCt) was determined by
subtracting the T/S ratio value of the 5 ng standard curve point from
the T/S ratio of each unknown sample (Cawthon, 2002).
For the overall controls, the mean T/S ratio was 1.20 (median,
1.13) with standard deviation of 0.41. There were 143 blinded
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quality control samples interspersed throughout the data set to assess
interplate and intraplate variability of Ct values. These quality
controls were duplicated samples in 22 sets. The interassay
coefficients of variation of the telomere and single-gene assay were
4.62 and 3.21%, respectively. The intraassay coefficients of variation
of the telomere and single-gene assay were 3.02 and 2.07%,
respectively.
Statistical methods
Spearman’s correlation coefficients were calculated to assess the
correlations among age, pack-years of smoking, other factors related
to skin cancer, and telomere length among controls only. Spear-
man’s partial correlation coefficients, adjusted for age, were used to
assess the correlations.
We examined the association between telomere length and each
type of skin cancer separately. We categorized telomere length into
quartiles according to the distribution in each cancer-specific control
population. We used conditional logistic regression to calculate OR
and 95% CIs. Tests for trend were conducted by assigning the
median values for quartiles of telomere length among controls to
both cases and controls as continuous variables.
To test statistical interactions between telomere length and the
number of moles on skin cancer risk, we modeled both predictors as
quartile ordinal variables to test the statistical significance of a single
multiplicative interaction term. The P-values are two sided; P-values
o0.05 were considered statistically significant. We used the SAS
Version 9.1 software (SAS Institute, Cary, NC).
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